An FDA recall on Allergan’s Biocell textured implants may affect some cross-fit trainers and yoga instructors in Los Angeles, but only about five percent of breast implants sold in the U.S. are textured, as opposed to smooth.
The U.S. Food and Drug Administration announced a voluntary nationwide recall of certain types of textured breast implants on Wednesday due to their cancer risk.

The manufacturer Allergan recalled its Biocell textured breast implants from suppliers and doctors’ offices, in order to protect from breast implant-associated anaplastic large cell lymphoma (BIA-ALCL).

Read the full story here: